Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group.

N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734.

2.

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.

Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J; OBIS Study Investigators.

Aliment Pharmacol Ther. 2011 Aug;34(4):432-42. doi: 10.1111/j.1365-2036.2011.04730.x. Epub 2011 Jun 16.

3.

[The first successful bilateral lung transplantation in Russia].

Iablonskiń≠ PK, Chuchalin AG, Massard Zh, Boiarkin AA, Avdeev SN, Pishchik VG, Stepanenko TA, Nikolaev GV, Filippova TA, Merzhoeva ZM, Sorokin MF, Nefedov AV, Kozak AR, Atiukov MA, Gorchakova IN, Kasherininova II, Klimko NN, Rukavishinikova SA, Akhmedov TA, Samsonova MV, Berkos AS, Figurin IS.

Vestn Khir Im I I Grek. 2007;166(1):88-95. Russian.

PMID:
17672117

Supplemental Content

Loading ...
Support Center